Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-07 |
mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | -0.23 | 7e-06 |
mRNA | austocystin d | CTRPv2 | pan-cancer | AAC | 0.17 | 1e-05 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.3 | 3e-05 |
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.27 | 5e-05 |
mRNA | YM-155 | GDSC1000 | pan-cancer | AAC | -0.15 | 5e-05 |
mRNA | BRD-K30019337 | CTRPv2 | pan-cancer | AAC | 0.29 | 7e-05 |
mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.14 | 0.0001 |
mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0002 |
mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0002 |